These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 35862646

  • 21. 18F-Labeled NaF PET-CT in Detection of Bone Metastases in Patients With Preoperative Lung Cancer.
    Rao L, Zong Z, Chen Z, Wang X, Shi X, Yi C, Zhang X.
    Medicine (Baltimore); 2016 Apr; 95(16):e3490. PubMed ID: 27100456
    [Abstract] [Full Text] [Related]

  • 22. Comparative study of 18F-DCFPyL PET/CT and 99mTc-MDP SPECT/CT bone imaging for the detection of bone metastases in prostate cancer.
    Hu X, Cao Y, Ji B, Zhao M, Wen Q, Chen B.
    Front Med (Lausanne); 2023 Apr; 10():1201977. PubMed ID: 37588003
    [Abstract] [Full Text] [Related]

  • 23. A comparative study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and (99m)Tc-MDP whole-body bone scanning for imaging osteolytic bone metastases.
    Zhang L, Chen L, Xie Q, Zhang Y, Cheng L, Li H, Wang J.
    BMC Med Imaging; 2015 Mar 01; 15():7. PubMed ID: 25885599
    [Abstract] [Full Text] [Related]

  • 24. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by 18F-FDG PET/CT. The role of 99mTc-MDP.
    Pietrzak A, Czepczynski R, Wierzchoslawska E, Cholewinski W.
    Hell J Nucl Med; 2017 Mar 01; 20(3):237-240. PubMed ID: 29177262
    [Abstract] [Full Text] [Related]

  • 25. Simultaneous PET/MRI in the Evaluation of Breast and Prostate Cancer Using Combined Na[18F] F and [18F]FDG: a Focus on Skeletal Lesions.
    Sonni I, Minamimoto R, Baratto L, Gambhir SS, Loening AM, Vasanawala SS, Iagaru A.
    Mol Imaging Biol; 2020 Apr 01; 22(2):397-406. PubMed ID: 31236756
    [Abstract] [Full Text] [Related]

  • 26. Is (99m)Tc-MDP whole body bone scintigraphy adjuvant to (18)F-FDG-PET for the detection of skeletal metastases?
    Sahin E, Zincirkeser S, Akcan AB, Elboga U.
    J BUON; 2014 Apr 01; 19(1):291-6. PubMed ID: 24659678
    [Abstract] [Full Text] [Related]

  • 27. 18F-NaF-PET/CT and 99mTc-MDP Bone Scintigraphy in the Detection of Bone Metastases in Prostate Cancer.
    Langsteger W, Rezaee A, Pirich C, Beheshti M.
    Semin Nucl Med; 2016 Nov 01; 46(6):491-501. PubMed ID: 27825429
    [Abstract] [Full Text] [Related]

  • 28. Comparison of the diagnostic value of 18F-NaF PET/CT and 99mTc-MDP SPECT for bone metastases: a systematic review and meta-analysis.
    Fan Z, Wang T, Zou L, Liu D.
    Transl Cancer Res; 2023 Nov 30; 12(11):3166-3178. PubMed ID: 38130318
    [Abstract] [Full Text] [Related]

  • 29. Intraindividual Comparison of 99mTc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand 99mTc-MIP-1427 in Patients with Osseous Metastasized Prostate Cancer.
    Rathke H, Afshar-Oromieh A, Giesel FL, Kremer C, Flechsig P, Haufe S, Mier W, Holland-Letz T, De Bucourt M, Armor T, Babich JW, Haberkorn U, Kratochwil C.
    J Nucl Med; 2018 Sep 30; 59(9):1373-1379. PubMed ID: 29371410
    [Abstract] [Full Text] [Related]

  • 30. Comparison of hybrid 68Ga-PSMA-PET/CT and 99mTc-DPD-SPECT/CT for the detection of bone metastases in prostate cancer patients: Additional value of morphologic information from low dose CT.
    Janssen JC, Meißner S, Woythal N, Prasad V, Brenner W, Diederichs G, Hamm B, Makowski MR.
    Eur Radiol; 2018 Feb 30; 28(2):610-619. PubMed ID: 28779400
    [Abstract] [Full Text] [Related]

  • 31. Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
    Iagaru A, Young P, Mittra E, Dick DW, Herfkens R, Gambhir SS.
    Clin Nucl Med; 2013 Jul 30; 38(7):e290-6. PubMed ID: 23455520
    [Abstract] [Full Text] [Related]

  • 32. The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan.
    Damle NA, Bal C, Bandopadhyaya GP, Kumar L, Kumar P, Malhotra A, Lata S.
    Jpn J Radiol; 2013 Apr 30; 31(4):262-9. PubMed ID: 23377765
    [Abstract] [Full Text] [Related]

  • 33. Diagnostic Challenge of Staging Metastatic Bone Disease in the Morbidly Obese Patients: A Primary Study Evaluating the Usefulness of 18F-Sodium Fluoride (NaF) PET-CT.
    Usmani S, Marafi F, Ahmed N, Esmail A, Al Kandari F, Van den Wyngaert T.
    Clin Nucl Med; 2017 Nov 30; 42(11):829-836. PubMed ID: 28872551
    [Abstract] [Full Text] [Related]

  • 34. 18F-Fluoride PET/CT and 99mTc-MDP SPECT/CT can detect bone cancer at early stage in rodents.
    Alves CRR, Faria DP, Carneiro CG, Garcez AT, Gutierrez VP, das Neves W, de Almeida NR, Cury Y, Chammas R, Brum PC.
    Life Sci; 2018 Aug 01; 206():29-34. PubMed ID: 29778807
    [Abstract] [Full Text] [Related]

  • 35. The value of 99mTc-methylene diphosphonate single photon emission computed tomography/computed tomography in diagnosis of fibrous dysplasia.
    Zhang L, He Q, Li W, Zhang R.
    BMC Med Imaging; 2017 Jul 24; 17(1):46. PubMed ID: 28738834
    [Abstract] [Full Text] [Related]

  • 36. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
    Chang CY, Gill CM, Joseph Simeone F, Taneja AK, Huang AJ, Torriani M, Bredella MA.
    Acta Radiol; 2016 Jan 24; 57(1):58-65. PubMed ID: 25533313
    [Abstract] [Full Text] [Related]

  • 37. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
    Ak I, Sivrikoz MC, Entok E, Vardareli E.
    Eur J Cardiothorac Surg; 2010 Apr 24; 37(4):792-6. PubMed ID: 20015657
    [Abstract] [Full Text] [Related]

  • 38. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
    Hsia TC, Shen YY, Yen RF, Kao CH, Changlai SP.
    Neoplasma; 2002 Apr 24; 49(4):267-71. PubMed ID: 12382027
    [Abstract] [Full Text] [Related]

  • 39. Molecular imaging in oncology: (18)F-sodium fluoride PET imaging of osseous metastatic disease.
    Mick CG, James T, Hill JD, Williams P, Perry M.
    AJR Am J Roentgenol; 2014 Aug 24; 203(2):263-71. PubMed ID: 25055258
    [Abstract] [Full Text] [Related]

  • 40. A Prospective Comparison of 18F-prostate-specific Membrane Antigen-1007 Positron Emission Tomography Computed Tomography, Whole-body 1.5 T Magnetic Resonance Imaging with Diffusion-weighted Imaging, and Single-photon Emission Computed Tomography/Computed Tomography with Traditional Imaging in Primary Distant Metastasis Staging of Prostate Cancer (PROSTAGE).
    Anttinen M, Ettala O, Malaspina S, Jambor I, Sandell M, Kajander S, Rinta-Kiikka I, Schildt J, Saukko E, Rautio P, Timonen KL, Matikainen T, Noponen T, Saunavaara J, Löyttyniemi E, Taimen P, Kemppainen J, Dean PB, Blanco Sequeiros R, Aronen HJ, Seppänen M, Boström PJ.
    Eur Urol Oncol; 2021 Aug 24; 4(4):635-644. PubMed ID: 32675047
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.